Bolongon, Rickwen .
HRN: 26-61-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFTRIAXONE 1G (VIAL)
01/28/2025
02/04/2025
IV
660 Mg
Q 24
Typhoid Fever; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes